<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:07:47Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5992133" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5992133</identifier><datestamp>2018-12-07</datestamp><setSpec>ajhg</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="brief-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am. J. Hum. Genet</journal-id>
      <journal-title-group>
        <journal-title>American Journal of Human Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0002-9297</issn>
      <issn pub-type="epub">1537-6605</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5992133</article-id>
      <article-id pub-id-type="pmcid">PMC5992133</article-id>
      <article-id pub-id-type="pmc-uid">5992133</article-id>
      <article-id pub-id-type="pmid">29861108</article-id>
      <article-id pub-id-type="publisher-id">S0002-9297(18)30161-7</article-id>
      <article-id pub-id-type="doi">10.1016/j.ajhg.2018.04.014</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>De Novo</italic> and Inherited Loss-of-Function Variants in <italic>TLK2</italic>: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Reijnders</surname>
            <given-names>Margot R.F.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn1" ref-type="fn">54</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miller</surname>
            <given-names>Kerry A.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn1" ref-type="fn">54</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alvi</surname>
            <given-names>Mohsan</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Goos</surname>
            <given-names>Jacqueline A.C.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lees</surname>
            <given-names>Melissa M.</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Burca</surname>
            <given-names>Anna</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Henderson</surname>
            <given-names>Alex</given-names>
          </name>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kraus</surname>
            <given-names>Alison</given-names>
          </name>
          <xref rid="aff8" ref-type="aff">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mikat</surname>
            <given-names>Barbara</given-names>
          </name>
          <xref rid="aff9" ref-type="aff">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Vries</surname>
            <given-names>Bert B.A.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Isidor</surname>
            <given-names>Bertrand</given-names>
          </name>
          <xref rid="aff10" ref-type="aff">10</xref>
          <xref rid="aff11" ref-type="aff">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kerr</surname>
            <given-names>Bronwyn</given-names>
          </name>
          <xref rid="aff12" ref-type="aff">12</xref>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marcelis</surname>
            <given-names>Carlo</given-names>
          </name>
          <xref rid="aff14" ref-type="aff">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schluth-Bolard</surname>
            <given-names>Caroline</given-names>
          </name>
          <xref rid="aff15" ref-type="aff">15</xref>
          <xref rid="aff16" ref-type="aff">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Deshpande</surname>
            <given-names>Charu</given-names>
          </name>
          <xref rid="aff17" ref-type="aff">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ruivenkamp</surname>
            <given-names>Claudia A.L.</given-names>
          </name>
          <xref rid="aff18" ref-type="aff">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wieczorek</surname>
            <given-names>Dagmar</given-names>
          </name>
          <xref rid="aff9" ref-type="aff">9</xref>
          <xref rid="aff19" ref-type="aff">19</xref>
        </contrib>
        <contrib contrib-type="author">
          <collab>The Deciphering Developmental Disorders Study</collab>
          <xref rid="aff20" ref-type="aff">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baralle</surname>
            <given-names>Diana</given-names>
          </name>
          <xref rid="aff21" ref-type="aff">21</xref>
          <xref rid="aff22" ref-type="aff">22</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Blair</surname>
            <given-names>Edward M.</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Engels</surname>
            <given-names>Hartmut</given-names>
          </name>
          <xref rid="aff23" ref-type="aff">23</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>LÃ¼decke</surname>
            <given-names>Hermann-Josef</given-names>
          </name>
          <xref rid="aff9" ref-type="aff">9</xref>
          <xref rid="aff19" ref-type="aff">19</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eason</surname>
            <given-names>Jacqueline</given-names>
          </name>
          <xref rid="aff24" ref-type="aff">24</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santen</surname>
            <given-names>Gijs W.E.</given-names>
          </name>
          <xref rid="aff18" ref-type="aff">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Clayton-Smith</surname>
            <given-names>Jill</given-names>
          </name>
          <xref rid="aff12" ref-type="aff">12</xref>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chandler</surname>
            <given-names>Kate</given-names>
          </name>
          <xref rid="aff12" ref-type="aff">12</xref>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tatton-Brown</surname>
            <given-names>Katrina</given-names>
          </name>
          <xref rid="aff25" ref-type="aff">25</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Payne</surname>
            <given-names>Katelyn</given-names>
          </name>
          <xref rid="aff26" ref-type="aff">26</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Helbig</surname>
            <given-names>Katherine</given-names>
          </name>
          <xref rid="aff27" ref-type="aff">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Radtke</surname>
            <given-names>Kelly</given-names>
          </name>
          <xref rid="aff27" ref-type="aff">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nugent</surname>
            <given-names>Kimberly M.</given-names>
          </name>
          <xref rid="aff28" ref-type="aff">28</xref>
          <xref rid="aff29" ref-type="aff">29</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cremer</surname>
            <given-names>Kirsten</given-names>
          </name>
          <xref rid="aff23" ref-type="aff">23</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Strom</surname>
            <given-names>Tim M.</given-names>
          </name>
          <xref rid="aff30" ref-type="aff">30</xref>
          <xref rid="aff31" ref-type="aff">31</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bird</surname>
            <given-names>Lynne M.</given-names>
          </name>
          <xref rid="aff32" ref-type="aff">32</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sinnema</surname>
            <given-names>Margje</given-names>
          </name>
          <xref rid="aff33" ref-type="aff">33</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bitner-Glindzicz</surname>
            <given-names>Maria</given-names>
          </name>
          <xref rid="aff34" ref-type="aff">34</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van Dooren</surname>
            <given-names>Marieke F.</given-names>
          </name>
          <xref rid="aff35" ref-type="aff">35</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alders</surname>
            <given-names>Marielle</given-names>
          </name>
          <xref rid="aff36" ref-type="aff">36</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koopmans</surname>
            <given-names>Marije</given-names>
          </name>
          <xref rid="aff18" ref-type="aff">18</xref>
          <xref rid="aff37" ref-type="aff">37</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brick</surname>
            <given-names>Lauren</given-names>
          </name>
          <xref rid="aff38" ref-type="aff">38</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kozenko</surname>
            <given-names>Mariya</given-names>
          </name>
          <xref rid="aff38" ref-type="aff">38</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harline</surname>
            <given-names>Megan L.</given-names>
          </name>
          <xref rid="aff28" ref-type="aff">28</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Klaassens</surname>
            <given-names>Merel</given-names>
          </name>
          <xref rid="aff39" ref-type="aff">39</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Steinraths</surname>
            <given-names>Michelle</given-names>
          </name>
          <xref rid="aff40" ref-type="aff">40</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cooper</surname>
            <given-names>Nicola S.</given-names>
          </name>
          <xref rid="aff41" ref-type="aff">41</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Edery</surname>
            <given-names>Patrick</given-names>
          </name>
          <xref rid="aff15" ref-type="aff">15</xref>
          <xref rid="aff16" ref-type="aff">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yap</surname>
            <given-names>Patrick</given-names>
          </name>
          <xref rid="aff42" ref-type="aff">42</xref>
          <xref rid="aff43" ref-type="aff">43</xref>
          <xref rid="aff44" ref-type="aff">44</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Terhal</surname>
            <given-names>Paulien A.</given-names>
          </name>
          <xref rid="aff37" ref-type="aff">37</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van der Spek</surname>
            <given-names>Peter J.</given-names>
          </name>
          <xref rid="aff45" ref-type="aff">45</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lakeman</surname>
            <given-names>Phillis</given-names>
          </name>
          <xref rid="aff36" ref-type="aff">36</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Taylor</surname>
            <given-names>Rachel L.</given-names>
          </name>
          <xref rid="aff12" ref-type="aff">12</xref>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Littlejohn</surname>
            <given-names>Rebecca O.</given-names>
          </name>
          <xref rid="aff28" ref-type="aff">28</xref>
          <xref rid="aff29" ref-type="aff">29</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pfundt</surname>
            <given-names>Rolph</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mercimek-Andrews</surname>
            <given-names>Saadet</given-names>
          </name>
          <xref rid="aff46" ref-type="aff">46</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stegmann</surname>
            <given-names>Alexander P.A.</given-names>
          </name>
          <xref rid="aff33" ref-type="aff">33</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kant</surname>
            <given-names>Sarina G.</given-names>
          </name>
          <xref rid="aff18" ref-type="aff">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McLean</surname>
            <given-names>Scott</given-names>
          </name>
          <xref rid="aff28" ref-type="aff">28</xref>
          <xref rid="aff29" ref-type="aff">29</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Joss</surname>
            <given-names>Shelagh</given-names>
          </name>
          <xref rid="aff47" ref-type="aff">47</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Swagemakers</surname>
            <given-names>Sigrid M.A.</given-names>
          </name>
          <xref rid="aff45" ref-type="aff">45</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Douzgou</surname>
            <given-names>Sofia</given-names>
          </name>
          <xref rid="aff12" ref-type="aff">12</xref>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wall</surname>
            <given-names>Steven A.</given-names>
          </name>
          <xref rid="aff48" ref-type="aff">48</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KÃ¼ry</surname>
            <given-names>SÃ©bastien</given-names>
          </name>
          <xref rid="aff49" ref-type="aff">49</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Calpena</surname>
            <given-names>Eduardo</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koelling</surname>
            <given-names>Nils</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McGowan</surname>
            <given-names>Simon J.</given-names>
          </name>
          <xref rid="aff50" ref-type="aff">50</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Twigg</surname>
            <given-names>Stephen R.F.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mathijssen</surname>
            <given-names>Irene M.J.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nellaker</surname>
            <given-names>Christoffer</given-names>
          </name>
          <xref rid="aff51" ref-type="aff">51</xref>
          <xref rid="aff52" ref-type="aff">52</xref>
          <xref rid="aff53" ref-type="aff">53</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brunner</surname>
            <given-names>Han G.</given-names>
          </name>
          <email>han.brunner@radboudumc.nl</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff33" ref-type="aff">33</xref>
          <xref rid="fn1" ref-type="fn">54</xref>
          <xref rid="cor1" ref-type="corresp">â</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wilkie</surname>
            <given-names>Andrew O.M.</given-names>
          </name>
          <email>andrew.wilkie@imm.ox.ac.uk</email>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="aff48" ref-type="aff">48</xref>
          <xref rid="fn1" ref-type="fn">54</xref>
          <xref rid="cor2" ref-type="corresp">ââ</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Department of Human Genetics, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, 6500 HB, the Netherlands</aff>
      <aff id="aff2"><label>2</label>Clinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK</aff>
      <aff id="aff3"><label>3</label>Visual Geometry Group, Department of Engineering Science, University of Oxford, Oxford OX1 2JD, UK</aff>
      <aff id="aff4"><label>4</label>Department of Plastic and Reconstructive Surgery, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, the Netherlands</aff>
      <aff id="aff5"><label>5</label>Department of Clinical Genetics, Great Ormond Street Hospital, London WC1N 3JH, UK</aff>
      <aff id="aff6"><label>6</label>Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7HE, UK</aff>
      <aff id="aff7"><label>7</label>Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 3BZ, UK</aff>
      <aff id="aff8"><label>8</label>Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds LS7 4SA, UK</aff>
      <aff id="aff9"><label>9</label>Institut fÃ¼r Humangenetik, UniversitÃ¤tsklinikum Essen, UniversitÃ¤t Duisburg-Essen, 45147 Essen, Germany</aff>
      <aff id="aff10"><label>10</label>CHU de Nantes, Service de GÃ©nÃ©tique MÃ©dicale, Nantes 44093 Cedex 1, France</aff>
      <aff id="aff11"><label>11</label>INSERM, UMR-S 957, 1 Rue Gaston Veil, Nantes 44035, France</aff>
      <aff id="aff12"><label>12</label>Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester M13 9PL, UK</aff>
      <aff id="aff13"><label>13</label>Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester M13 9WL, UK</aff>
      <aff id="aff14"><label>14</label>Department of Human Genetics, Radboud University Medical Center, Nijmegen 6500 HB, the Netherlands</aff>
      <aff id="aff15"><label>15</label>Hospices Civils de Lyon, Service de GÃ©nÃ©tique, Centre de RÃ©fÃ©rence Anomalies du DÃ©veloppement, 69500 Bron, France</aff>
      <aff id="aff16"><label>16</label>INSERM U1028, CNRS UMR5292, UCB Lyon 1, Centre de Recherche en Neurosciences de Lyon, GENDEV Team, 69500 Bron, France</aff>
      <aff id="aff17"><label>17</label>South East Thames Regional Genetics Service, Guyâs Hospital, London SE1 9RT, UK</aff>
      <aff id="aff18"><label>18</label>Department of Clinical Genetics, Leiden University Medical Center, 2300 RC Leiden, the Netherlands</aff>
      <aff id="aff19"><label>19</label>Institute of Human Genetics, Heinrich-Heine-University, Medical Faculty, 40225 DÃ¼sseldorf, Germany</aff>
      <aff id="aff20"><label>20</label>Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK</aff>
      <aff id="aff21"><label>21</label>Human Development and Health, Duthie Building, University of Southampton, Southampton SO16 6YD, UK</aff>
      <aff id="aff22"><label>22</label>Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton SO16 5YA, UK</aff>
      <aff id="aff23"><label>23</label>Institute of Human Genetics, University of Bonn, School of Medicine &amp; University Hospital Bonn, 53127 Bonn, Germany</aff>
      <aff id="aff24"><label>24</label>Nottingham Regional Genetics Service, City Hospital Campus, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK</aff>
      <aff id="aff25"><label>25</label>Southwest Thames Regional Genetics Centre, St Georgeâs University Hospitals NHS Foundation Trust, St Georgeâs University of London, London SW17 0RE, UK</aff>
      <aff id="aff26"><label>26</label>Riley Hospital for Children, Indianapolis, Indiana, IN 46202, USA</aff>
      <aff id="aff27"><label>27</label>Division of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA 92656, USA</aff>
      <aff id="aff28"><label>28</label>Department of Pediatrics, Baylor College of Medicine, The Childrenâs Hospital of San Antonio, San Antonio, TX 78207, USA</aff>
      <aff id="aff29"><label>29</label>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA</aff>
      <aff id="aff30"><label>30</label>Institute of Human Genetics, Helmholtz Zentrum MÃ¼nchen, 85764 Neuherberg, Germany</aff>
      <aff id="aff31"><label>31</label>Institute of Human Genetics, Technische UniversitÃ¤t MÃ¼nchen, 81675 Munich, Germany</aff>
      <aff id="aff32"><label>32</label>University of California, San Diego, Department of Pediatrics; Genetics and Dysmorphology, Rady Childrenâs Hospital San Diego, San Diego, CA 92123, USA</aff>
      <aff id="aff33"><label>33</label>Department of Clinical Genetics and School for Oncology &amp; Developmental Biology (GROW), Maastricht University Medical Center, Maastricht 6229 ER, the Netherlands</aff>
      <aff id="aff34"><label>34</label>Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK</aff>
      <aff id="aff35"><label>35</label>Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 21455, 3001 AL Rotterdam, the Netherlands</aff>
      <aff id="aff36"><label>36</label>Department of Clinical Genetics, Academic Medical Center, PO Box 22660, 1100 DD Amsterdam, the Netherlands</aff>
      <aff id="aff37"><label>37</label>Department of Genetics, University Medical Center Utrecht, 3508 AB Utrecht, the Netherlands</aff>
      <aff id="aff38"><label>38</label>Division of Genetics, Department of Pediatrics, McMaster Childrenâs Hospital, McMaster University, Hamilton, ON L8N 3Z5, Canada</aff>
      <aff id="aff39"><label>39</label>Department of Paediatrics, Maastricht University Medical Center, Maastricht 6229 ER, the Netherlands</aff>
      <aff id="aff40"><label>40</label>Department of Medical Genetics, University of British Columbia, Vancouver, BC V8Z 6R5, Canada</aff>
      <aff id="aff41"><label>41</label>West Midlands Regional Clinical Genetics Unit, Birmingham Womenâs &amp; Childrenâs NHS Foundation Trust, Mindelsohn Way, Birmingham B15 2TG, UK</aff>
      <aff id="aff42"><label>42</label>Genetic Health Service New Zealand, Auckland 1142, New Zealand</aff>
      <aff id="aff43"><label>43</label>Victorian Clinical Genetic Services, Murdoch Childrenâs Research Institute, Melbourne, VIC 3052, Australia</aff>
      <aff id="aff44"><label>44</label>University of Auckland, Auckland 1142, New Zealand</aff>
      <aff id="aff45"><label>45</label>Department of Pathology &amp; Department of Bioinformatics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, the Netherlands</aff>
      <aff id="aff46"><label>46</label>Division of Clinical and Metabolic Genetics, Department of Pediatrics, University of Toronto, Toronto, ON, Canada; Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON M5G 1X8, Canada</aff>
      <aff id="aff47"><label>47</label>West of Scotland Clinical Genetics Service, Queen Elizabeth University Hospital, Glasgow G51 4TF, UK</aff>
      <aff id="aff48"><label>48</label>Craniofacial Unit, Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Oxford OX3 9DU, UK</aff>
      <aff id="aff49"><label>49</label>CHU de Nantes, Service de GÃ©nÃ©tique MÃ©dicale, 44093 Nantes Cedex 1, France</aff>
      <aff id="aff50"><label>50</label>Computational Biology Research Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK</aff>
      <aff id="aff51"><label>51</label>Nuffield Department of Womenâs and Reproductive Health, University of Oxford, Womenâs Centre, John Radcliffe Hospital, Oxford OX3 9DS, UK</aff>
      <aff id="aff52"><label>52</label>Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford OX3 7FZ, UK</aff>
      <aff id="aff53"><label>53</label>Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7FZ, UK</aff>
      <author-notes>
        <corresp id="cor1"><label>â</label>Corresponding author <email>han.brunner@radboudumc.nl</email></corresp>
        <corresp id="cor2"><label>ââ</label>Corresponding author <email>andrew.wilkie@imm.ox.ac.uk</email></corresp>
        <fn id="fn1">
          <label>54</label>
          <p id="ntpara0010">These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>07</day>
        <month>6</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>5</month>
        <year>2018</year>
      </pub-date>
      <volume>102</volume>
      <issue>6</issue>
      <fpage>1195</fpage>
      <lpage>1203</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>2</month>
          <year>2018</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>4</month>
          <year>2018</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2018 The Authors</copyright-statement>
        <copyright-year>2018</copyright-year>
        <license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
        </license>
      </permissions>
      <abstract id="abs0010">
        <p>Next-generation sequencing is a powerful tool for the discovery of genes related to neurodevelopmental disorders (NDDs). Here, we report the identification of a distinct syndrome due to <italic>de novo</italic> or inherited heterozygous mutations in Tousled-like kinase 2 (<italic>TLK2</italic>) in 38 unrelated individuals and two affected mothers, using whole-exome and whole-genome sequencing technologies, matchmaker databases, and international collaborations. Affected individuals had a consistent phenotype, characterized by mild-borderline neurodevelopmental delay (86%), behavioral disorders (68%), severe gastro-intestinal problems (63%), and facial dysmorphism including blepharophimosis (82%), telecanthus (74%), prominent nasal bridge (68%), broad nasal tip (66%), thin vermilion of the upper lip (62%), and upslanting palpebral fissures (55%). Analysis of cell lines from three affected individuals showed that mutations act through a loss-of-function mechanism in at least two case subjects. Genotype-phenotype analysis and comparison of computationally modeled faces showed that phenotypes of these and other individuals with loss-of-function variants significantly overlapped with phenotypes of individuals with other variant types (missense and C-terminal truncating). This suggests that haploinsufficiency of TLK2 is the most likely underlying disease mechanism, leading to a consistent neurodevelopmental phenotype. This work illustrates the power of international data sharing, by the identification of 40 individuals from 26 different centers in 7 different countries, allowing the identification, clinical delineation, and genotype-phenotype evaluation of a distinct NDD caused by mutations in <italic>TLK2.</italic></p>
      </abstract>
      <kwd-group id="kwrds0010">
        <title>Keywords</title>
        <kwd>Tousled-like</kwd>
        <kwd>kinase</kwd>
        <kwd>haploinsufficiency</kwd>
        <kwd>facial averaging</kwd>
        <kwd>intellectual disability</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <p id="misc0010">Published: May 31, 2018</p>
    </notes>
  </front>
  <body>
    <sec id="sec1">
      <title>Main Text</title>
      <p id="p0010">The introduction of whole-exome sequencing (WES) as a diagnostic test for individuals with unexplained neurodevelopmental disorders (NDDs) has led to the identification of dozens of disease-associated genes. As a recent example, statistical analysis of aggregated exome data uncovered variants in ten different genes as likely causes of intellectual disability, a subtype of NDDs characterized by deficits in both intellectual and adaptive functioning.<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref> One such gene was Tousled-like kinase 2 (<italic>TLK2</italic> [MIM: <ext-link ext-link-type="omim" xlink:href="608439" id="intref0010">608439</ext-link>]), which was originally named because of homology to the <italic>Arabidopsis</italic> gene <italic>Tousled</italic>.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref>
<italic>TLK2</italic>, ubiquitously expressed in all tissues including fetal brain, encodes a serine/threonine kinase comprising a catalytic domain and multiple highly conserved coiled-coil motifs.<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib4" ref-type="bibr">4</xref> TLK2 is known to have maximal activity during the S-phase of the cell cycle and is therefore tightly linked to DNA replication.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> DNA double-strand breaks lead to rapid and transient inhibition of TLK activity, suggesting a role in checkpoint regulation.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> With the discovery of both H3-H4 chaperone Asf1 and histone H3 as physiological substrates of TLKs, its protein function has been linked to chromatin assembly.<xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib10" ref-type="bibr">10</xref></p>
      <p id="p0015">To establish the contribution of <italic>TLK2</italic> variants to NDDs in humans, we systematically collected phenotypic data of the five affected individuals with <italic>TLK2</italic> variants reported previously,<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> derived cell lines, and exploited different strategies to identify additional individuals with a variant in this gene. By including <italic>TLK2</italic> in a Deciphering Developmental Disorders<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> Complementary Analysis Project, by using of GeneMatcher,<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> and by sharing data with international collaborators, we identified a total of 38 unrelated individuals and two affected mothers with heterozygous variants in <italic>TLK2</italic>. Variants were detected by either family-based WES (research settings, n = 18 probands and 2 affected parents; diagnostic settings, n = 18 probands) or whole-genome sequencing (WGS) (research settings, nÂ =Â 2 probands) in 26 different institutions and 7 different countries (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S1</xref>; <xref rid="mmc1" ref-type="supplementary-material">Supplemental Subjects and Methods</xref>). Two additional individuals with <italic>de novo TLK2</italic> variants c.1514T&gt;A (p.Val505Asp) and c.2171G&gt;A (p.Arg724Gln), each of whom had a second likely pathogenic mutation in another gene, were excluded from further consideration to avoid confounding in the phenotypic analysis (<xref rid="mmc1" ref-type="supplementary-material">Supplemental Subjects and Methods</xref>). IRB-approved consents for WES or WGS in diagnostic or research settings were obtained for all individuals.</p>
      <p id="p0020">We observed a broad spectrum of different variant types in <italic>TLK2</italic> (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_006852" id="intref0015">NM_006852</ext-link>): 4 frameshift variants, 10 nonsense variants (including 2 located in the last exon), 12 canonical splice-site variants, and 9 missense variants (<xref rid="fig1" ref-type="fig">Figures 1</xref>Aâ1C; <xref rid="tbl1" ref-type="table">Table 1</xref>). Additionally, we identified a <italic>de novo</italic> balanced translocation in one of the WGS case subjects, resulting in a breakpoint at chromosome 17q23.2 disrupting the <italic>TLK2</italic> intron between exons 2 and 3 (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>D; <xref rid="mmc1" ref-type="supplementary-material">Supplemental Subjects and Methods</xref>). Interestingly, we found recurrent mutations within our cohort of affected individuals, occurring at hypermutable sites as reported by Rahbari etÂ al.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> We considered the alternative possibility of gene conversion, because pseudogenes very similar to <italic>TLK2</italic> exist at 10p11.21 and/or 17q12; however, the pseudogene sequence(s) at the site of each recurrent mutation correspond to wild-type <italic>TLK2</italic>, excluding this mechanism. The missense variants c.1487A&gt;G (p.His496Arg) and c.1015C&gt;T (p.Arg339Trp) were each identified in two unrelated individuals, and c.1016G&gt;A (p.Arg339Gln) also occurs at the Arg339 codon (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>C; <xref rid="tbl1" ref-type="table">Table 1</xref>). Finally, two splice variants were predicted to give rise to the same affected protein product: c.1286+1G&gt;T and c.1286+1G&gt;A (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>B; <xref rid="tbl1" ref-type="table">Table 1</xref>). From the 9 missense variants identified in 11 unrelated individuals, 5 are located in the catalytic domain of the protein and 3 in a coiled-coil motif. One variant, c.890G&gt;A (p.Gly297Asp), is located outside a known functional domain, but affects a highly conserved amino acid and was predicted pathogenic by several <italic>in silico</italic> prediction programs, similar to other missense variants (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>C; <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>). None of the missense variants were present in the ExAC database,<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> nor in our in-house database of variants identified in healthy control subjects. The recently released gnomAD database, containing WGS variants identified in control subjects, reported only c.1636C&gt;T (p.Arg546Trp) in a single individual (allele frequency of â¼0.000004). None of the other missense variants were present in the gnomAD database (<xref rid="tbl1" ref-type="table">Table 1</xref>).<fig id="fig1"><label>FigureÂ 1</label><caption><p>Intragenic Variants and Balanced Translocation Identified in <italic>TLK2</italic></p><p>(A) Location of <italic>TLK2</italic> (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_006852.3" id="intref0065">NM_006852.3</ext-link>) on chromosome 17q23.2 (see <xref rid="mmc1" ref-type="supplementary-material">Supplemental Subjects and Methods</xref> for discussion about different <italic>TLK2</italic> spliceforms). Vertical marks in <italic>TLK2</italic> represent the 22 exons. Green arrow indicates region enlarged in panel below.</p><p>(B) Schematic view (not to scale) of exonsÂ 11â22 and locations of 12 identifiedÂ splice site mutations (green crosses). The splice site mutation inherited from an affected parent is shown in bold and green. The variant subjected to cDNA analysis is shown in the dark green rectangle.</p><p>(C) Overview of TLK2 protein with the protein kinase domain (dark green) and three coiled-coil motifs (light green). Loss-of-function variants (24 total, including 8 nonsense, 4 frameshift, and 12Â splice site mutations) are shown aboveÂ the protein with green crosses indicating positions of splice site mutations. Other variants (11 missense variants and 2 nonsense variants causing aÂ premature stop codon in the last exon)Â are shown below the protein. The frameshift mutation inherited from an affected parent is shown in bold and green. The variants subjected to cDNA analysis are shown in the dark green rectangles.</p><p>(D) Balanced translocation between chromosomes 4 and 17, with the breakpoint disrupting <italic>TLK2</italic> between exons 2 and 3, identified in one individual: 46,XX,t(4;17)(27;q23.2).seq[GRCh37]t(4;17)g.[chr4:pter_cen_122332907:: chr17:60,581,319_qter]g.[chr17_pter_cen_60,581,315::chr4:122,332,920_qter].</p><p>(E) Pedigrees of individuals with inherited variants and photographs of probands and their affected mothers. Both mothers have facial dysmorphism similar to their children. WT, wild-type at variant position.</p></caption><graphic xlink:href="gr1"/></fig><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Intragenic Variants in <italic>TLK2</italic> (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_006852.3" id="intref0070">NM_006852.3</ext-link>), Inheritance, and Presence in ExAC and gnomAD Databases</p></caption><table frame="hsides" rules="groups"><thead><tr><th><bold>Subgroup</bold></th><th><bold>cDNA Position</bold></th><th><bold>Protein Position</bold></th><th><bold>Inheritance</bold></th><th><bold>RNA Analysis</bold></th><th><bold>cMAF ExAC</bold></th><th><bold>cMAF gnomAD</bold></th></tr></thead><tbody><tr><td rowspan="24">Predicted LOF</td><td>c.37C&gt;T</td><td>p.Gln13<sup>â</sup></td><td><italic>de novo</italic></td><td>no</td><td rowspan="24">no LOF variants</td><td rowspan="24">5 LOF variants: â¼0.00002</td></tr><tr><td>c.181C&gt;T</td><td>p.Arg61<sup>â</sup></td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.202G&gt;T</td><td>p.Glu68<sup>â</sup></td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.685_688del</td><td>p.Glu229Argfs<sup>â</sup>6</td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.777C&gt;A</td><td>p.Tyr259<sup>â</sup></td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.784C&gt;T</td><td>p.Arg262<sup>â</sup></td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.832â1G&gt;A</td><td>unknown</td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.907C&gt;T</td><td>p.Arg303<sup>â</sup></td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.968+1del</td><td>unknown</td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.989C&gt;A</td><td>p.Ser330<sup>â</sup></td><td><italic>de novo</italic></td><td>yes</td></tr><tr><td>c.1121+1G&gt;A</td><td>unknown</td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.1122â1G&gt;T</td><td>unknown</td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.1286+1G&gt;T</td><td>unknown</td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.1286+1G&gt;A</td><td>unknown</td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.1460+2T&gt;G</td><td>unknown</td><td>inherited</td><td>no</td></tr><tr><td>c.1550+1G&gt;A</td><td>unknown</td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.1651C&gt;T</td><td>p.Gln551<sup>â</sup></td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.1672dup</td><td>p.Tyr558Leufs<sup>â</sup>4</td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.1720+1G&gt;T<xref rid="tblfn1" ref-type="table-fn">a</xref></td><td>unknown</td><td><italic>de novo</italic></td><td>yes</td></tr><tr><td>c.1746delA</td><td>p.Ala583Argfs<sup>â</sup>5</td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.1776_1783delTGGTCTTT</td><td>p.Gly593Glufs<sup>â</sup>5</td><td>inherited</td><td>no</td></tr><tr><td>c.1860â1G&gt;T</td><td>unknown</td><td>unknown</td><td>no</td></tr><tr><td>c.1972â2A&gt;G</td><td>unknown</td><td><italic>de novo</italic></td><td>no</td></tr><tr><td>c.2079+1G&gt;A</td><td>unknown</td><td><italic>de novo</italic></td><td>no</td></tr><tr><td rowspan="11">Other variant types</td><td>c.2092C&gt;T<xref rid="tblfn1" ref-type="table-fn">a</xref></td><td>p.Arg698<sup>â</sup></td><td><italic>de novo</italic></td><td>yes</td><td>0</td><td>0</td></tr><tr><td>c.2170C&gt;T</td><td>p.Arg724<sup>â</sup></td><td><italic>de novo</italic></td><td>no</td><td>0</td><td>0</td></tr><tr><td>c.890G&gt;A</td><td>p.Gly297Asp</td><td><italic>de novo</italic></td><td>no</td><td>0</td><td>0</td></tr><tr><td>c.1015C&gt;T</td><td>p.Arg339Trp</td><td><italic>de novo</italic><xref rid="tblfn2" ref-type="table-fn">b</xref></td><td>no</td><td>0</td><td>0</td></tr><tr><td>c.1016G&gt;A</td><td>p.Arg339Gln</td><td><italic>de novo</italic></td><td>no</td><td>0</td><td>0</td></tr><tr><td>c.1273G&gt;A</td><td>p.Glu425Lys</td><td>unknown</td><td>no</td><td>0</td><td>0</td></tr><tr><td>c.1412A&gt;G<xref rid="tblfn1" ref-type="table-fn">a</xref></td><td>p.His471Arg</td><td><italic>de novo</italic></td><td>no</td><td>0</td><td>0</td></tr><tr><td>c.1487A&gt;G<xref rid="tblfn1" ref-type="table-fn">a</xref></td><td>p.His496Arg</td><td><italic>de novo</italic><xref rid="tblfn2" ref-type="table-fn">b</xref></td><td>no</td><td>0</td><td>0</td></tr><tr><td>c.1636C&gt;T</td><td>p.Arg546Trp</td><td><italic>de novo</italic></td><td>no</td><td>0</td><td>â¼0.000004</td></tr><tr><td>c.1819G&gt;A<xref rid="tblfn1" ref-type="table-fn">a</xref></td><td>p.Asp607Asn</td><td><italic>de novo</italic></td><td>no</td><td>0</td><td>0</td></tr><tr><td>c.1973C&gt;G</td><td>p.Pro658Arg</td><td><italic>de novo</italic></td><td>no</td><td>0</td><td>0</td></tr></tbody></table><table-wrap-foot><fn><p>Identified balanced translocation (n = 1) is not included in this table. Abbreviations: cMAF, cumulative minor allele frequency; LOF, loss-of-function</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn1"><label>a</label><p id="ntpara0015">Variant reported previously<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref></p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn2"><label>b</label><p id="ntpara0020">Recurrent <italic>de novo</italic> variant identified in two unrelated individuals</p></fn></table-wrap-foot></table-wrap></p>
      <p id="p0025">For all but two variants (<xref rid="tbl1" ref-type="table">Table 1</xref>), the <italic>de novo</italic> status was assessed by sequencing the parents of the proband. In two individuals, variants were inherited from a similarly affected parent, while all other variants (n = 34) occurred <italic>de novo</italic>. Detailed phenotyping revealed that both mothers carrying a predicted loss-of-function (LOF) <italic>TLK2</italic> variant (<xref rid="tbl1" ref-type="table">Table 1</xref>) were mildly affected. The first mother (c.1460+2T&gt;G) had mild neurodevelopmental delay and speechÂ delay. The second affected mother (c.1776_1783delTGGTCTTT [p.Gly593Glufs<sup>â</sup>5]) had a low-normal IQ level but was diagnosed with bipolar disorder. Both had facial dysmorphism similar to their affected children (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>E). The inherited variants illustrate that the search for a diagnosis should not always be restricted to <italic>de novo</italic> mutations, in particular if individuals are only mildly affected. Similar to the parents in this study, who were never referred for genetic testing before investigation of their child uncovered a <italic>TLK2</italic> variant, we expect mutations causing milder phenotypes to be present in the general population. This could explain why, although <italic>TLK2</italic> exhibits very strong constraint against LOF variants (pLIÂ = 1), five LOF variants (low-coverage variants excluded) have been reported in gnomAD, and a missense variantâc.1636C&gt;T (p.Arg546Trp)âthat was reported here as <italic>de novo</italic> variant, was present at very low allele frequency in the population (aggregate minor allele frequency of LOF and missense variants â¼0.000024).</p>
      <p id="p0030">Consistent with the phenotypes of both affected mothers, mild neurodevelopmental phenotypes accompanied by language and motor delay were present in the majority of the 38 unrelated probands: 6% of the individuals had normal IQ levels (85â100), 14% had borderline ID (IQ 70â85), and from the 72% diagnosed with ID (IQ &lt; 70), most had mild ID (IQ 50â70) (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>). Most of the affected probands (22 males and 16 females) were children at the time of last examination (median 8.0 years; interquartile range 4.1â13.5 years); ages ranged between 3Â months and 29 years. Three individuals, who all had language and motor delay, were too young for formal assessment of their neurodevelopmental phenotype. In addition to this, systematic evaluation of other clinical data, scored by the referring clinician, showed a variety of overlapping features (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>, <xref rid="mmc1" ref-type="supplementary-material">Table S2</xref>). Neurological problems including hypotonia (37%), epilepsy (13%), and non-specific intracranial brain abnormalities (13%) (<xref rid="mmc1" ref-type="supplementary-material">Table S3</xref>) were observed. A broad range of behavioral disorders was present (68%), with often severely affected social functioning: tantrums (11 individuals), autism spectrum disorder (ASD; 11 individuals), attention-deficit disorder with or without hyperactivity (ADHD; 5 individuals), and severe social-emotional problems (6 individuals) were the most commonly reported problems. Less frequently observed were short attention span, pica disorder, aggression, obsessive-compulsive disorder, and anxiety in 11 individuals. Other recurrent features included gastro-intestinal problems (constipation in 55%; severe diarrhea in 8%), neonatal feeding difficulties (42%), eye abnormalities (refraction abnormality in 29%, strabismus in 26%), musculoskeletal abnormalities (joint hypermobility in 21%; pes planus in 21%; toe walking in 18%; scoliosis in 8%; contractures of the hands in 8%), recurrent otitis media (24%), hypertrichosis (16%), and hoarse voice (8%). Abnormalities of skull shape were observed in 31% of probands (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>, <xref rid="mmc1" ref-type="supplementary-material">Tables S2</xref> and <xref rid="mmc1" ref-type="supplementary-material">S4</xref>), with clinically proven craniosynostosis being present in four (11%)Â of them (<xref rid="mmc1" ref-type="supplementary-material">Table S5</xref>). However, sequence-based screening of 309 DNA samples from individuals with mixed, genetically undiagnosed craniosynostosis (<xref rid="mmc1" ref-type="supplementary-material">Supplemental Subjects and Methods</xref>, <xref rid="mmc1" ref-type="supplementary-material">Table S6</xref>) did not identify further case subjects, indicating that <italic>TLK2</italic> mutations are aÂ rare cause of craniosynostosis. Growth parameters were frequently abnormal (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>). Short stature was documented in 37%, microcephaly in 24% (primary in 13%, secondary in 3%, and unknown age of onset in 8%), and low body weight in 13%. Three individuals (8%) were overweight, with age of onset between the ages of 2 and 12 years. Features reported in only one or two individuals are summarized in <xref rid="mmc1" ref-type="supplementary-material">Table S4</xref>. In addition to the other clinical features, overlapping facial dysmorphisms were present (<xref rid="fig3" ref-type="fig">Figures 3</xref>A and 3B). Most frequently reported by clinicians were blepharophimosis (82%), telecanthus (74%), prominent nasal bridge (68%), broad nasal tip (66%), thin vermilion of the upper lip (62%), and upslanting palpebral fissures (55%). Pointed and tall chin (42%), epicanthal folds (42%), narrow mouth (32%), high palate (30%), microtia, first degree (29%), posteriorly rotated ears (29%), long face (27%), ptosis (21%), and asymmetric face (16%) were observed in fewer than half of the individuals.<fig id="fig2"><label>FigureÂ 2</label><caption><p>Clinical Spectrum Associated with <italic>TLK2</italic> Variants</p><p>Overview of clinical features observed in individuals with <italic>TLK2</italic> variants.</p></caption><graphic xlink:href="gr2"/></fig><fig id="fig3"><label>FigureÂ 3</label><caption><p>Facial Dysmorphism of Individuals with <italic>TLK2</italic> Variants</p><p>(A) Photographs of 21 unrelated individuals with a loss-of-function variant in <italic>TLK2</italic>, showing overlapping facial dysmorphism. Most frequently reported by clinicians were blepharophimosis, telecanthus, prominent nasal bridge, broad nasal tip, thin vermilion upper lip, and upward slanted palpebral fissures. Pointed and tall chin, epicanthal folds, narrow mouth, high palate, microtia, posteriorly rotated ears, long face, ptosis, and asymmetric face were observed in fewer than half of the individuals.</p><p>(B) Photographs of seven unrelated individuals with a missense or C-terminal truncating variant in TLK2. Variant c.2170C&gt;T (p.Arg724<sup>â</sup>) is assigned to this subgroup, since a premature stop codon is introduced in the last exon. Facial dysmorphisms overlapped with dysmorphism observed in individuals with loss-of-function variants.</p><p>(C) Computational averaging of 33 facial photographs of 22 subjects with LOF variants in <italic>TLK2</italic> (left) compared with 22 gender- and age-matched control subjects (right).</p><p>(D) Computational averaging of 11 facial photographs of 8 subjects with missense or C-terminal truncating variants in <italic>TLK2</italic> (left) compared with 8 gender- and age-matched control subjects (right).</p></caption><graphic xlink:href="gr3"/></fig></p>
      <p id="p0035">Analysis of data from the ExAC database demonstrates that <italic>TLK2</italic> is extremely intolerant for LOF variants (pLI score = 1).<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> In line with this observation, animal models with depletion of TLK2 have been reported to have severely disturbed cellular and developmental processes. <italic>Drosophila</italic> with complete LOF of TLK were associated with arrested nuclear divisions, causing apoptosis of the cell.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref>
<italic>Tlk2</italic>-null mice were embryonically lethal due to placental failure.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> In this study, we found several predicted LOF variants in affected individuals. To investigate whether variants resulted in an aberrant transcript, we synthesized cDNA from RNA extracted from fibroblast or lymphoblastoid cell lines (<xref rid="mmc1" ref-type="supplementary-material">Supplemental Subjects and Methods</xref>, <xref rid="mmc1" ref-type="supplementary-material">Table S7</xref>) from three individuals with different variants: (1) c.989C&gt;A (p.Ser330<sup>â</sup>), predicted to result inÂ a truncated product leading to nonsense-mediated decay (NMD); (2) c.2092C&gt;T (p.Arg698<sup>â</sup>), with a premature stop codon in the last exon predicted to escape from NMD; and (3) c.1720+1G&gt;T, a mutation predicted to affect splicing of exon 18. To investigate the significance of NMD for expression of <italic>TLK2</italic> transcripts, we treated fibroblasts (for p.Ser330<sup>â</sup>) and lymphoblastoid cell lines (for p.Ser330<sup>â</sup>, p.Arg698<sup>â</sup>, and c.1720+1G&gt;T) with cycloheximide, an inhibitor of NMD.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> Transcript stability of cDNA PCR products from p.Ser330<sup>â</sup> and p.Arg698<sup>â</sup> individuals in the presence of cycloheximide was analyzed using a restriction enzyme assay targeting the wild-type transcript and the results were confirmed using deep sequencing to quantify relative levels of wild-type and mutant transcripts (<xref rid="mmc1" ref-type="supplementary-material">Supplemental Subjects and Methods</xref>). For fibroblast and lymphoblastoid cell lines heterozygous for the p.Ser330<sup>â</sup> variant, the mutant allele represented 15.8% and 21.5% of transcripts, respectively, in the absence of cycloheximide, but rose to 37.7% and 48.5%, respectively, in theÂ presence of cycloheximide, supporting that this variant is subject to NMD and causes haploinsufficiency of TLK2. In contrast, wild-type and mutant transcripts from lymphoblastoid cells of the individual heterozygous for p.Arg698<sup>â</sup> did not show significant differences between treated and untreated cells, supporting that the mutant transcript escapes NMD due to its location within the lastÂ coding exon of <italic>TLK2</italic> (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>A). Amplification of cDNA from an individual with a splice-site variant (c.1720+1G&gt;T) showed a full-length wild-type product of 300Â bp and an additional aberrant smaller product of 130Â bp, consistent with skipping of exon 18. Direct sequencing of this smaller fragment confirmed that exonÂ 17 spliced directly to exon 19, thereby producing an out-of-frame transcript predicted to introduce a premature stop codon at the next amino acid position (p.Ser517fs<sup>â</sup>1). Additionally, the intensity of the spliced transcript increased when treated with cycloheximide, indicating that the mutant transcript is subjected to NMD (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>B).<fig id="fig4"><label>FigureÂ 4</label><caption><p>Analysis of <italic>TLK2</italic> Transcripts in Cell Lines</p><p>(A) Analysis of transcripts encoding nonsense mutations c.989C&gt;A (p.Ser330<sup>â</sup>) and c.2092C&gt;T (p.Arg698<sup>â</sup>) in cell lines of affected individuals. Left panel shows reverse transcriptase-PCR (RT-PCR) products of cDNA prepared from fibroblast and lymphoblastoid cell lines of subject with p.Ser330<sup>â</sup> variant, either in the presence (+C) or absence (âC) of cycloheximide and incubated with ApoI (digests wild-type allele). Central panel shows RT-PCR of cDNA prepared from lymphoblastoid cell line of subject with p.Arg698<sup>â</sup> variant, in the presence (+C) or absence (âC) of cycloheximide and incubated with Hpy99I (digests wild-type allele). Right panel showsÂ proportion (Â±standard deviation) of variant alleles quantified by deep sequencing of triplicate samples. Statistical testing of differences: <sup>â</sup>p = 0.046; <sup>ââ</sup>p = 0.011; NS, not significant.</p><p>(B) Analysis of transcripts with canonical splice-site mutation c.1720+1G&gt;T. A wild-type fragment at 300Â bp in c.1720+1G&gt;T lymphoblastoid cells is observed as well as a second fragment at 130Â bp, which is absent in control cDNA. An increase of mutant transcript in cells was present when treated with cycloheximide (+C), indicating that the aberrant transcript was subject to NMD. Sequencing of the 300Â bp (white box) and 130Â bp (green box) fragments demonstrated skipping of exon 18 in the lower cDNA product. Abbreviations: Fibs, fibroblasts; EBV, lymphoblastoid cells; C/CHX, cycloheximide; WT, control cDNA.</p></caption><graphic xlink:href="gr4"/></fig></p>
      <p id="p0040">By analyzing <italic>TLK2</italic> transcripts in cell lines of three different individuals, we were able to confirm that transcripts were subjected to NMD in two of them, causing haploinsufficiency of TLK2. It is likely that comparable variants predicted to cause LOF of TLK2 affect the transcript similarly. The large number of identified individuals with <italic>TLK2</italic> variants allowed us to search for underlying pathogenic mechanisms for the individuals with variants with unknown effect, such as p.Arg698<sup>â</sup>. To assess this, we divided our cohort in two subgroups and (1) performed a structured genotype-phenotype analysis and (2) created and compared computationally modeled faces. Subgroup 1 (n = 25) included all probands carrying a predicted LOF variant (nonsense, frameshift or canonical splice-site, or balanced translocation) similar to variants p.Ser330<sup>â</sup> and c.1720+1G&gt;T. Subgroup 2 (n = 13) comprised individuals with either missense variants or variants introducing a premature stop codon in the last exon of <italic>TLK2</italic>, such as p.Arg698<sup>â</sup>. Affected parents of probands with inherited mutations were not included in the subgroups. Next, we compared frequencies of 40 different features and frequencies of 15 facial dysmorphisms between the two groups via a two-tailed Fisherâs exact test. This showed that both clinical features and facial dysmorphisms were remarkably similar between the two subgroups. From the 55 different features, none differed significantly between the two subgroups (p &lt; 0.05), even without correction for multiple testing (<xref rid="mmc1" ref-type="supplementary-material">Table S2</xref>). Second, averaged visualization of facial dysmorphism by computational modeling of 33 photographs from 22 individuals in subgroup 1 compared with 11 photographs from 8 individuals in subgroup 2 at different ages (<xref rid="mmc1" ref-type="supplementary-material">Supplemental Subjects and Methods</xref>) showed consistent differences from a comparable number of gender- and age-matched controls, including blepharophimosis, telecanthus, broad nasal tip, and tall, pointed chin (<xref rid="fig3" ref-type="fig">Figures 3</xref>C and 3D). Given this strong overlap in phenotypes and facial dysmorphic features between probands with different type of mutations, it is likely that not only LOF variants but also the majority of identified missense variants and variants with a premature stop codon in the last exon have only a single functional copy of <italic>TLK2</italic>. Hence, we conclude that the predominant pathogenic mechanism of these <italic>TLK2</italic> mutations is haploinsufficiency.</p>
      <p id="p0045">Often mentioned together with TLK2 is its close interactor TLK1. From birth, murine <italic>Tlk2</italic> shows a similar expression pattern to the closely related paralog <italic>Tlk1</italic> across many tissues.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> Human TLK1 has 84% identity to TLK2 at the protein level,<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> and it was shown that TLK1 depletion leads to extensive chromosome segregation defects in human cells.<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> Interestingly, <italic>TLK1</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="608438" id="intref0020">608438</ext-link>) is (similarly to <italic>TLK2</italic>) intolerant for both missense and truncating mutations in healthy individuals (significant z-scores of 3.84 [<italic>TLK1</italic>] and 5.67 [<italic>TLK2</italic>] and pLI [constraint] scores of 1.00 for both TLK1 and TLK2) (ExAC database).<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> In theÂ literature, four <italic>de novo</italic> variants have been reported in <italic>TLK1</italic> (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_012290.4" id="intref0025">NM_012290.4</ext-link>): c.74C&gt;T (p.Pro25Leu) inÂ an individual with intellectual disability,<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> c.1697T&gt;C (p.Met566Thr) in an individual with autism,<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> c.1796C&gt;G (p.Ala599Gly) in an individual with a NDD and congenital heart disease,<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> and c.1101del (p.Lys367Asnfs<sup>â</sup>25) in an individual with schizophrenia.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> Importantly, none of these variants are present in the ExAC or gnomAD databases. Taking this into account, it is possible that <italic>TLK1</italic> variants could contribute to NDDs, similar to the homolog <italic>TLK2</italic>. In future research, the exact role of <italic>TLK1</italic> in NDDs should be further explored.</p>
      <p id="p0050">In conclusion, we show that both <italic>de novo</italic> and inherited mutations in <italic>TLK2</italic> cause a distinct neurodevelopmental disorder, hallmarked by mild developmental delay, a variety of behavioral disorders, severe gastro-intestinal problems, and facial dysmorphism. The identification of a large number of individuals (n = 40, including two affected mothers) emphasizes the power and importance of data sharing, allowing us to delineate the clinical phenotype and to evaluate genotype-phenotype correlations. More than two-thirds of the individuals were identified in two relatively small countries: the Netherlands and the UK (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S1</xref>). With an estimated prevalence of â¼1/566 (17/9,625) of <italic>TLK2</italic> variants in probands recruited to the DDD study, it is expected that a larger number of individuals with <italic>TLK2</italic> variants is present world-wide. In future, even more extensive data sharing than performed in this study will be needed to further extend the <italic>TLK2</italic> cohort. By analyzing three cell lines of affected individuals, we were able to confirm that at least two variants act through a heterozygous loss-of-function mechanism (haploinsufficiency). The phenotypes of these individuals and others with comparable loss-of-function variants significantly overlapped with phenotypes of individuals with other variant types, providing further evidence for the underlying disease mechanism of the <italic>TLK2</italic> variants. Given the genetic and functional similarities between TLK2 and TLK1, further research should focus on the potential role of <italic>TLK1</italic> mutations in developmental disorders.</p>
    </sec>
    <sec id="sec2">
      <title>Declaration of Interests</title>
      <p id="p0055">The authors declare no competing interests.</p>
    </sec>
  </body>
  <back>
    <ref-list id="cebib0010">
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal" id="sref1">
          <person-group person-group-type="author">
            <name>
              <surname>Lelieveld</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Reijnders</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Pfundt</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Yntema</surname>
              <given-names>H.G.</given-names>
            </name>
            <name>
              <surname>Kamsteeg</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>de Vries</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>de Vries</surname>
              <given-names>B.B.</given-names>
            </name>
            <name>
              <surname>Willemsen</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Kleefstra</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>LÃ¶hner</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability</article-title>
          <source>Nat. Neurosci.</source>
          <volume>19</volume>
          <year>2016</year>
          <fpage>1194</fpage>
          <lpage>1196</lpage>
          <pub-id pub-id-type="pmid">27479843</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <mixed-citation publication-type="other" id="sref2">American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (Washington, DC).</mixed-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal" id="sref3">
          <person-group person-group-type="author">
            <name>
              <surname>SilljÃ©</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Van Houwe</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Nigg</surname>
              <given-names>E.A.</given-names>
            </name>
          </person-group>
          <article-title>Mammalian homologues of the plant Tousled gene code for cell-cycle-regulated kinases with maximal activities linked to ongoing DNA replication</article-title>
          <source>EMBO J.</source>
          <volume>18</volume>
          <year>1999</year>
          <fpage>5691</fpage>
          <lpage>5702</lpage>
          <pub-id pub-id-type="pmid">10523312</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal" id="sref4">
          <person-group person-group-type="author">
            <name>
              <surname>Yamakawa</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kameoka</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yoshitake</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Nishikawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Tanihara</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Date</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>cDNA cloning and chromosomal mapping of genes encoding novel protein kinases termed PKU-alpha and PKU-beta, which have nuclear localization signal</article-title>
          <source>Gene</source>
          <volume>202</volume>
          <year>1997</year>
          <fpage>193</fpage>
          <lpage>201</lpage>
          <pub-id pub-id-type="pmid">9427565</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal" id="sref5">
          <person-group person-group-type="author">
            <name>
              <surname>Groth</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lukas</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Nigg</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>SilljÃ©</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Wernstedt</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bartek</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint</article-title>
          <source>EMBO J.</source>
          <volume>22</volume>
          <year>2003</year>
          <fpage>1676</fpage>
          <lpage>1687</lpage>
          <pub-id pub-id-type="pmid">12660173</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal" id="sref6">
          <person-group person-group-type="author">
            <name>
              <surname>SilljÃ©</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Nigg</surname>
              <given-names>E.A.</given-names>
            </name>
          </person-group>
          <article-title>Identification of human Asf1 chromatin assembly factors as substrates of Tousled-like kinases</article-title>
          <source>Curr. Biol.</source>
          <volume>11</volume>
          <year>2001</year>
          <fpage>1068</fpage>
          <lpage>1073</lpage>
          <pub-id pub-id-type="pmid">11470414</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal" id="sref7">
          <person-group person-group-type="author">
            <name>
              <surname>Carrera</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Moshkin</surname>
              <given-names>Y.M.</given-names>
            </name>
            <name>
              <surname>Gronke</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sillje</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Nigg</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Jackle</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Karch</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Tousled-like kinase functions with the chromatin assembly pathway regulating nuclear divisions</article-title>
          <source>Genes Dev.</source>
          <volume>17</volume>
          <year>2003</year>
          <fpage>2578</fpage>
          <lpage>2590</lpage>
          <pub-id pub-id-type="pmid">14561777</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal" id="sref8">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>DeFatta</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Anthony</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Sunavala</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>De Benedetti</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>A translationally regulated Tousled kinase phosphorylates histone H3 and confers radioresistance when overexpressed</article-title>
          <source>Oncogene</source>
          <volume>20</volume>
          <year>2001</year>
          <fpage>726</fpage>
          <lpage>738</lpage>
          <pub-id pub-id-type="pmid">11314006</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal" id="sref9">
          <person-group person-group-type="author">
            <name>
              <surname>Klimovskaia</surname>
              <given-names>I.M.</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>StrÃ¸mme</surname>
              <given-names>C.B.</given-names>
            </name>
            <name>
              <surname>Menard</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Jasencakova</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Mejlvang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ask</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ploug</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nielsen</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>O.N.</given-names>
            </name>
            <name>
              <surname>Groth</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Tousled-like kinases phosphorylate Asf1 to promote histone supply during DNA replication</article-title>
          <source>Nat. Commun.</source>
          <volume>5</volume>
          <year>2014</year>
          <fpage>3394</fpage>
          <pub-id pub-id-type="pmid">24598821</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal" id="sref10">
          <person-group person-group-type="author">
            <name>
              <surname>Bruinsma</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>van den Berg</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Aprelia</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Medema</surname>
              <given-names>R.H.</given-names>
            </name>
          </person-group>
          <article-title>Tousled-like kinase 2 regulates recovery from a DNA damage-induced G2 arrest</article-title>
          <source>EMBO Rep.</source>
          <volume>17</volume>
          <year>2016</year>
          <fpage>659</fpage>
          <lpage>670</lpage>
          <pub-id pub-id-type="pmid">26931568</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal" id="sref11">
          <person-group person-group-type="author">
            <collab>Deciphering Developmental Disorders Study</collab>
          </person-group>
          <article-title>Prevalence and architecture of <italic>de novo</italic> mutations in developmental disorders</article-title>
          <source>Nature</source>
          <volume>542</volume>
          <year>2017</year>
          <fpage>433</fpage>
          <lpage>438</lpage>
          <pub-id pub-id-type="pmid">28135719</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal" id="sref12">
          <person-group person-group-type="author">
            <name>
              <surname>Sobreira</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schiettecatte</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Valle</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hamosh</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>GeneMatcher: a matching tool for connecting investigators with an interest in the same gene</article-title>
          <source>Hum. Mutat.</source>
          <volume>36</volume>
          <year>2015</year>
          <fpage>928</fpage>
          <lpage>930</lpage>
          <pub-id pub-id-type="pmid">26220891</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal" id="sref13">
          <person-group person-group-type="author">
            <name>
              <surname>Rahbari</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Wuster</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lindsay</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Hardwick</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Alexandrov</surname>
              <given-names>L.B.</given-names>
            </name>
            <name>
              <surname>Turki</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Dominiczak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Porteous</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>B.</given-names>
            </name>
            <collab>UK10K Consortium</collab>
          </person-group>
          <article-title>Timing, rates and spectra of human germline mutation</article-title>
          <source>Nat. Genet.</source>
          <volume>48</volume>
          <year>2016</year>
          <fpage>126</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="pmid">26656846</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal" id="sref14">
          <person-group person-group-type="author">
            <name>
              <surname>Lek</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Karczewski</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Minikel</surname>
              <given-names>E.V.</given-names>
            </name>
            <name>
              <surname>Samocha</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Banks</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Fennell</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>OâDonnell-Luria</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>Ware</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Cummings</surname>
              <given-names>B.B.</given-names>
            </name>
            <collab>Exome Aggregation Consortium</collab>
          </person-group>
          <article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>
          <source>Nature</source>
          <volume>536</volume>
          <year>2016</year>
          <fpage>285</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="pmid">27535533</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal" id="sref15">
          <person-group person-group-type="author">
            <name>
              <surname>Segura-Bayona</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Knobel</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>GonzÃ¡lez-BurÃ³n</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Youssef</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>PeÃ±a-Blanco</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Coyaud</surname>
              <given-names>Ã.</given-names>
            </name>
            <name>
              <surname>LÃ³pez-Rovira</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Rein</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Palenzuela</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Colombelli</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Differential requirements for Tousled-like kinases 1 and 2 in mammalian development</article-title>
          <source>Cell Death Differ.</source>
          <volume>24</volume>
          <year>2017</year>
          <fpage>1872</fpage>
          <lpage>1885</lpage>
          <pub-id pub-id-type="pmid">28708136</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal" id="sref16">
          <person-group person-group-type="author">
            <name>
              <surname>Ishigaki</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Serin</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Maquat</surname>
              <given-names>L.E.</given-names>
            </name>
          </person-group>
          <article-title>Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20</article-title>
          <source>Cell</source>
          <volume>106</volume>
          <year>2001</year>
          <fpage>607</fpage>
          <lpage>617</lpage>
          <pub-id pub-id-type="pmid">11551508</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal" id="sref17">
          <person-group person-group-type="author">
            <name>
              <surname>Hashimoto</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Matsui</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Iwabuchi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Date</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>PKU-beta/TLK1 regulates myosin II activities, and is required for accurate equaled chromosome segregation</article-title>
          <source>Mutat. Res.</source>
          <volume>657</volume>
          <year>2008</year>
          <fpage>63</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="pmid">18838128</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal" id="sref18">
          <person-group person-group-type="author">
            <name>
              <surname>De Rubeis</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Poultney</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Samocha</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Cicek</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Kou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Fromer</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>S.</given-names>
            </name>
            <collab>DDD Study</collab>
            <collab>Homozygosity Mapping Collaborative for Autism</collab>
            <collab>UK10K Consortium</collab>
          </person-group>
          <article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>
          <source>Nature</source>
          <volume>515</volume>
          <year>2014</year>
          <fpage>209</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="pmid">25363760</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal" id="sref19">
          <person-group person-group-type="author">
            <name>
              <surname>Homsy</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zaidi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ware</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Samocha</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Karczewski</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>DePalma</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>McKean</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Wakimoto</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Gorham</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies</article-title>
          <source>Science</source>
          <volume>350</volume>
          <year>2015</year>
          <fpage>1262</fpage>
          <lpage>1266</lpage>
          <pub-id pub-id-type="pmid">26785492</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <element-citation publication-type="journal" id="sref20">
          <person-group person-group-type="author">
            <name>
              <surname>Fromer</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pocklington</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Kavanagh</surname>
              <given-names>D.H.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Dwyer</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Gormley</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Georgieva</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Rees</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Palta</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Ruderfer</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>De novo mutations in schizophrenia implicate synaptic networks</article-title>
          <source>Nature</source>
          <volume>506</volume>
          <year>2014</year>
          <fpage>179</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="pmid">24463507</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="app3">
      <title>Web Resources</title>
      <p id="p0075">
        <list list-type="simple" id="ulist0010">
          <list-item id="u0010">
            <p id="p0080">DECIPHER, <ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/" id="intref0035">https://decipher.sanger.ac.uk/</ext-link></p>
          </list-item>
          <list-item id="u0015">
            <p id="p0085">ExAC Browser, v.0.3.1, <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/" id="intref0040">http://exac.broadinstitute.org/</ext-link></p>
          </list-item>
          <list-item id="u0020">
            <p id="p0090">GenBank, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/genbank/" id="intref0045">https://www.ncbi.nlm.nih.gov/genbank/</ext-link></p>
          </list-item>
          <list-item id="u0025">
            <p id="p0095">GeneMatcher, <ext-link ext-link-type="uri" xlink:href="https://genematcher.org/" id="intref0050">https://genematcher.org/</ext-link></p>
          </list-item>
          <list-item id="u0030">
            <p id="p0100">gnomAD Browser, v.r2.0.2, <ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org/" id="intref0055">http://gnomad.broadinstitute.org/</ext-link></p>
          </list-item>
          <list-item id="u0035">
            <p id="p0105">OMIM, <ext-link ext-link-type="uri" xlink:href="http://www.omim.org/" id="intref0060">http://www.omim.org/</ext-link></p>
          </list-item>
        </list>
      </p>
    </sec>
    <sec id="app2" sec-type="supplementary-material">
      <title>Supplemental Data</title>
      <p id="p0070">
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Document S1. FigureÂ S1, Tables S1âS7, and Supplemental Subjects and Methods</title>
          </caption>
          <media xlink:href="mmc1.pdf"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc2">
          <caption>
            <title>Document S2. Article plus Supplemental Data</title>
          </caption>
          <media xlink:href="mmc2.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack id="ack0010">
      <title>Acknowledgments</title>
      <p>We thank H. Mlcochova, V.P. Sharma, and M. van Zeijl for technical support. We thank Sandra Yang for her help in contacting referring clinicians from GeneDx. This project was supported by the <funding-source id="gs1">French Ministry of Health (DGOS)</funding-source> and the <funding-source id="gs2">French National Agency for Research (ANR)</funding-source> (PRTS 2013 grant to C.S.-B.), the <funding-source id="gs3">MRC</funding-source> through a Skills Development Fellowship (MR/R024952/1 to R.L.T.), <funding-source id="gs4">Methodology Research Fellowship</funding-source> (MR/M014568/1 to C.N.), the <funding-source id="gs5">Weatherall Institute of Molecular Medicine Strategic Alliance</funding-source> (G0902418, MC_UU_12025), the <funding-source id="gs6">National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme</funding-source> (A.O.M.W.), and <funding-source id="gs7">Wellcome Investigator Award</funding-source> 102731 (A.O.M.W.). All research at Great Ormond Street Hospital NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health is made possible by the NIHR Great Ormond Street Hospital Biomedical Research Centre. The DDD study presents independent research commissioned by the <funding-source id="gs8">Health Innovation Challenge Fund</funding-source> (grant number HICF-1009-003), a parallel funding partnership between the <funding-source id="gs9">Wellcome Trust and the Department of Health</funding-source>,Â and the <funding-source id="gs10">Wellcome Trust Sanger Institute</funding-source> (grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The research team acknowledges the support of the NIHR, through the Comprehensive Clinical Research Network. This study makes use of DECIPHER, which is funded by the <funding-source id="gs11">Wellcome Trust</funding-source>. ErasmusMC acknowledges Complete Genomics which donated 100 WGS trios for the centennial anniversary of the Erasmus University. J.A.C.G. was supported by the <funding-source id="gs12">Innovation Fund</funding-source> (project number 2922). We acknowledge the HUGODIMS consortium, which was supported by a grant from the <funding-source id="gs13">French Ministry of Health</funding-source> and from the <funding-source id="gs14">Health Regional Agency from Poitou-Charentes</funding-source> (HUGODIMS, 2013, RC14_0107); we are grateful to FrÃ©dÃ©rique Allaire from the Health Regional Agency of Poitou-Charentes for supporting this project.</p>
    </ack>
    <fn-group>
      <fn id="app1" fn-type="supplementary-material">
        <p id="p0065">Supplemental Data include one figure, seven tables, and Supplemental Subjects and Methods and can be found with this article online at <ext-link ext-link-type="doi" xlink:href="10.1016/j.ajhg.2018.04.014" id="intref0030">https://doi.org/10.1016/j.ajhg.2018.04.014</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>